Wilmer Cutler Pickering Hale and Dorr advised ImmPACT Bio on the deal. ImmPACT Bio, a clinical-stage company developing transformative logic-gate based chimeric antigen receptor (CAR) T-cell...
This content is for Standard 1 Year members only. LoginJoin Now